common.study.topics.clinical

Diffuse Optical Monitoring with Inhaled Nitric Oxide

common.study.values.description

Diffuse Optical Monitoring With Inhaled Nitric Oxide

This study is a non-randomized, Phase 2 clinical trial designed to measure the cerebral blood flow (CBF) response to inhaled nitric oxide in acute ischemic stroke patients and healthy subjects. The monitoring is a 35 minute session during which cerebral hemodynamics will be monitored with both diffuse correlation spectroscopy (DCS) and transcranial doppler ultrasonography (TCD) while blood pressure, heart rate, cardiac output, respiratory rate, end oxygen saturation, and inhaled nitric oxide (NO)/nitrogen dioxide (NO2) concentration, are continuously monitored.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - Nitric Oxide

Inhaled Nitric Oxide gas

participant.views.study.view.additional

participant.views.study.view.scientific-title

Diffuse Optical Monitoring With Inhaled Nitric Oxide

common.study.values.clinical-trial-id

NCT03023449

participant.views.study.view.id

QeZNwe